Shanghai Runda Medical Technology Co., Ltd. (SHSE: 603108)
Health Care · Life Sciences Tools & Services · CN
CN¥9.97
-0.10% today · -36.5% 1Y
Shanghai Runda Medical Technology Co., Ltd. (SHSE: 603108) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $898.64M and employs 2,945 people.
Over the last twelve months the share price has lost 36.5%, trading between 8.70 and 20.77.
Tweenvest scores Shanghai Runda Medical Technology Co., Ltd. across four factors: quality 53/100, value 48/100, growth 0/100. Its strongest factor is quality.
603108 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $898.64M
- Revenue (TTM)
- $989.54M
- P/E
- —
- EPS
- -0.85
- Dividend yield
- —
- Beta (5Y)
- 0.54
- 52-week high
- CN¥20.77
- 52-week low
- CN¥8.70
- Avg volume (3M)
- —
- Shares outstanding
- 604.60M
- Employees
- 2,945
- Next earnings
- —
About Shanghai Runda Medical Technology Co., Ltd.
Shanghai Runda Medical Technology Co., Ltd. delivers a comprehensive array of integrated medical laboratory solutions throughout China. The company's extensive offerings cover vital operational aspects for laboratories, including the provision of essential platforms, expert design and refurbishment services for facilities, the establishment of standardization protocols, and the implementation of advanced information management systems. Furthermore, Shanghai Runda supports healthcare professionals by providing medical solutions for critical diagnostic fields such as biochemistry, diabetes, Point-of-Care Testing (POCT), immunoassay analysis, and molecular biology. Alongside these, they also furnish professional technical assistance and efficient logistical services. Established in 1999, the firm is headquartered in Shanghai, China.
- ISIN
- CNE100002318
- Founded
- 1999
- Listed since
- May 27, 2015
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PharmaResources (Shanghai) Co., Ltd.SZSE: 301230 | $1.03B | CN¥38.48 | +0.79% |
| Anhui Wanbang Pharmaceutical Technology Co.,Ltd.SZSE: 301520 | $982.60M | CN¥71.05 | -4.23% |
| R&G PharmaStudies Co., Ltd.SZSE: 301333 | $952.14M | CN¥66.67 | +3.70% |
| Suven Life Sciences LimitedBSE: 530239 | $905.38M | Rs308.50 | -7.90% |
| Cryoport, Inc.NasdaqCM: CYRX | $882.81M | $16.90 | -3.04% |
| Maccura Biotechnology Co.LtdSZSE: 300463 | $859.07M | CN¥9.53 | +2.47% |
| Boji Medical Technology Co.,Ltd.SZSE: 300404 | $841.23M | CN¥14.73 | +2.01% |
| Shanghai Obio Technology (Group) Corp., Ltd.SHSE: 688238 | $831.61M | CN¥8.85 | +3.87% |
Figures last refreshed Oct 4, 2026.